Drug Target Review

JULY 11, 2025

From maths and physics to molecular biology Schnall-Levin did not begin in the life sciences. “I I started looking around and getting interested in biology. I got my eyes opened to molecular biology, bioinformatics, computational biology and these emerging fields at the time.”

Molecular Biology 69

Molecular Biology Disease Therapies Bioinformatics 69

Drug Target Review

JUNE 14, 2025

I began in bioinformatics, conducting lab-based genomics work but soon felt the need to dive deeper into the computational side. Ian Kerman (IK): My name is Ian Kerman and I’m currently a data science and AI solutions architect at Certara. I’ve been in the scientific informatics space for over 15 years.

Laboratories 69

Laboratories Science Bioinformatics Molecular Biology 69

Drug Target Review

JUNE 26, 2025

Ian earned an MS in computer science, focusing on machine learning, from the Georgia Institute of Technology, as well as an MS in biology, alongside undergraduate degrees in bioinformatics and molecular biology, from the University of California, San Diego.

Laboratories 52

Laboratories Science Molecular Biology Bioinformatics 52

Codon

JULY 21, 2025

We need to help the Spinozas of bioinformatics grind out new lenses. Beyond better tooling, biology would benefit greatly from more efforts to find true organizing principles and patterns. We’ve known about base pairs, RNA, and DNA for decades, but we couldn't make full use of them because our tools were so poor.

Science 79

Science DNA Engineering RNA 79

Elrig

APRIL 29, 2024

With a background in Bioinformatics and Computational Biology, she has a keen interest in using technology to solve problems in healthcare and medicine. Bioinformatics is all about bringing together different areas of knowledge. Do you think the current talent pool supply meets the demand?

Bioinformatics 59

Bioinformatics Drugs Molecular Biology Cell Based Assays 59

Drug Target Review

MAY 27, 2024

His research expertise focused on the use of genomics in translational oncology with a focus on clinical trials, genomically-informed drug combinations, liquid biopsy & MRD, and creating novel bioinformatic pipelines for cancer genome analyses.

Clinical Trials 59

Clinical Trials Science Molecular Biology Bioinformatics 59

The Open Targets Blog

APRIL 25, 2023

Each Christmas presented the opportunity for the leaders to make fools of themselves in the annual pantomime, a tradition which we had inherited from the MRC Laboratory of Molecular Biology (LMB) in Cambridge and perhaps from earlier scientists who had known ENSA during service in the War. Comput Appl Biosci 13, 523–535 (1997).

DNA 52

DNA Government Engineering Laboratories 52